BioStock: BiBBInstruments initiates clinical trial in bladder cancer

BiBBInstruments' EndoDrill Model X is undergoing clinical evaluation as a potential game changer in the field of cancer diagnostics. Last year, the first clinical trial began targeting cancer of the upper gastrointestinal tract. Yesterday, the company announced the recruitment of the first patient in a second trial targeting bladder cancer. BiBBInstrument’s electric endoscopic biopsy device could prevent patients with muscle invasive bladder cancerfrom undergoing a major procedure called TURBT (Transurethral Resection for Bladder Tumour) and thus shorten the time to treatment. TURBT is an invasive surgical procedure currently used for diagnosis and treatment.

Read the full article at biostock.se:

https://www.biostock.se/en/bibbinstruments-initiates-clinical-trial-in-bladder-cancer/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se